Literature DB >> 11333899

Identification of the regions of Fv1 necessary for murine leukemia virus restriction.

K N Bishop1, M Bock, G Towers, J P Stoye.   

Abstract

The Fv1 gene restricts murine leukemia virus replication via an interaction with the viral capsid protein. To study this interaction, a number of mutations, including a series of N-terminal and C-terminal deletions, internal deletions, and a number of single-amino-acid substitutions, were introduced into the n and b alleles of the Fv1 gene and the effects of these changes on virus restriction were measured. A significant fraction of the Fv1 protein was not required for restriction; however, retention of an intact major homology region as well as of domains toward the N and C termini was essential. Binding specificity appeared to be a combinatorial property of a number of residues within the C-terminal portion of Fv1.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11333899      PMCID: PMC114923          DOI: 10.1128/JVI.75.11.5182-5188.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

Review 1.  The Fv-1 gene of the mouse and its control of murine leukemia virus replication.

Authors:  P Jolicoeur
Journal:  Curr Top Microbiol Immunol       Date:  1979       Impact factor: 4.291

2.  RNA sequencing provides evidence for allelism of determinants of the N-, B- or NB-tropism of murine leukemia viruses.

Authors:  J Rommelaere; H Donis-Keller; N Hopkins
Journal:  Cell       Date:  1979-01       Impact factor: 41.582

3.  Transfer of Fv-1 locus-specific resistance to murine N-tropic and B-tropic retroviruses by cytoplasmic RNA.

Authors:  W K Yang; R W Tennant; R J Rascati; J A Otten; B Schluter; J O Kiggans; F E Myer; A Brown
Journal:  J Virol       Date:  1978-08       Impact factor: 5.103

4.  Fv-2: identification and location of a second gene governing the spleen focus response to Friend leukemia virus in mice.

Authors:  F Lilly
Journal:  J Natl Cancer Inst       Date:  1970-07       Impact factor: 13.506

5.  Nucleotide sequences of gag-pol regions that determine the Fv-1 host range property of BALB/c N-tropic and B-tropic murine leukemia viruses.

Authors:  C Y Ou; L R Boone; C K Koh; R W Tennant; W K Yang
Journal:  J Virol       Date:  1983-12       Impact factor: 5.103

6.  Solution structure of the capsid protein from the human T-cell leukemia virus type-I.

Authors:  S Khorasanizadeh; R Campos-Olivas; M F Summers
Journal:  J Mol Biol       Date:  1999-08-13       Impact factor: 5.469

7.  Solution structure and dynamics of the Rous sarcoma virus capsid protein and comparison with capsid proteins of other retroviruses.

Authors:  R Campos-Olivas; J L Newman; M F Summers
Journal:  J Mol Biol       Date:  2000-02-18       Impact factor: 5.469

8.  Six-NB-tropic murine leukemia viruses derived from a B-tropic virus of BALB/c have altered p30.

Authors:  N Hopkins; J Schindler; R Hynes
Journal:  J Virol       Date:  1977-01       Impact factor: 5.103

9.  Host-range restrictions of murine leukemia viruses in mouse embryo cell cultures.

Authors:  J W Hartley; W P Rowe; R J Huebner
Journal:  J Virol       Date:  1970-02       Impact factor: 5.103

10.  Physical mapping of the Fv-1 tropism host range determinant of BALB/c murine leukemia viruses.

Authors:  L DesGroseillers; P Jolicoeur
Journal:  J Virol       Date:  1983-12       Impact factor: 5.103

View more
  36 in total

1.  An intracellular block to primate lentivirus replication.

Authors:  Jonathan P Stoye
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-23       Impact factor: 11.205

2.  Retroviral capsid determinants of Fv1 NB and NR tropism.

Authors:  Anthony Stevens; Michael Bock; Scott Ellis; Paul LeTissier; Kate N Bishop; Melvyn W Yap; Willie Taylor; Jonathan P Stoye
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

3.  A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1.

Authors:  Sébastien Nisole; Clare Lynch; Jonathan P Stoye; Melvyn W Yap
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

4.  Balancing selection and the evolution of functional polymorphism in Old World monkey TRIM5alpha.

Authors:  Ruchi M Newman; Laura Hall; Michelle Connole; Guo-Lin Chen; Shuji Sato; Eloisa Yuste; William Diehl; Eric Hunter; Amitinder Kaur; Gregory M Miller; Welkin E Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-01       Impact factor: 11.205

5.  Isolation, characterization, and genetic complementation of a cellular mutant resistant to retroviral infection.

Authors:  Sumit Agarwal; Josephine Harada; Jeffrey Schreifels; Patrycja Lech; Bryan Nikolai; Tomoyuki Yamaguchi; Sumit K Chanda; Nikunj V Somia
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-16       Impact factor: 11.205

Review 6.  Host restriction factors blocking retroviral replication.

Authors:  Daniel Wolf; Stephen P Goff
Journal:  Annu Rev Genet       Date:  2008       Impact factor: 16.830

7.  Identification of quantitative trait loci for susceptibility to mouse adenovirus type 1.

Authors:  Amanda R Welton; Elissa J Chesler; Carla Sturkie; Anne U Jackson; Gwen N Hirsch; Katherine R Spindler
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  Trim5alpha protein restricts both HIV-1 and murine leukemia virus.

Authors:  Melvyn W Yap; Sébastien Nisole; Clare Lynch; Jonathan P Stoye
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

9.  Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production.

Authors:  Vasundhara Varthakavi; Rita M Smith; Stephan P Bour; Klaus Strebel; Paul Spearman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

10.  Unexpected inheritance: multiple integrations of ancient bornavirus and ebolavirus/marburgvirus sequences in vertebrate genomes.

Authors:  Vladimir A Belyi; Arnold J Levine; Anna Marie Skalka
Journal:  PLoS Pathog       Date:  2010-07-29       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.